Understanding how a patient’s body processes a drug is the key to matching the right drug to the right individual and avoiding drug-gene interactions or DGIs. A study conducted by a multidisciplinary team, including Amy Pasternak, PharmD, clinical assistant professor of pharmacy, and clinical pharmacist at Michigan Medicine, analyzed how common it is to experience a DGI and ways to make better recommendations for patient care. Pasternak explores the study and key findings, including that almost one-quarter of patients had more than one DGI, suggesting the value of testing and the need to track these results across a patient’s lifetime.
